Opportunities
Search

Buyer: Nacionālais veselības dienests | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-10

Buyer: Pleno del Ayuntamiento de Miranda de Ebro | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-10

Buyer: HOCH Health Ostschweiz, Departement Immobilien und Betrieb | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-10

Buyer: SILENE HABITAT | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-07-10

Buyer: GRAND PORT MARITIME DE MARSEILLE | Notice type: cn-standard | Contract: services | Deadline: 2026-07-10

Buyer: CH AGEN-NERAC | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-10

Buyer: Commune de LE COUDRAY | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-10

Buyer: MAIRIE DE BEAUMONT DE LOMAGNE | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-10

Buyer: Chemins de fer fédéraux suisses CFF, Infrastructure - Achat, Supply Chain et Production, Achat Construction Site de Berne | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-07-10

Buyer: CAP LAN | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-10

Buyer: EKT AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-10

Buyer: SBB CFF FFS Achats projets de construction Région Ouest | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-07-10

Buyer: PP ELT, Standort Mainz, Abt. BuL, SG ZB1 | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-10

Buyer: Valsts aizsardzības loģistikas un iepirkumu centrs | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-10

Buyer: Landkreis Stade | Notice type: cn-standard | Procedure: oth-single | Contract: services | Deadline: 2026-07-10

Buyer: Comune di Novara | Notice type: cn-standard | Contract: services | Deadline: 2026-07-10

Buyer: Gemeente Zaanstad | Notice type: cn-social | Procedure: open | Contract: services | Deadline: 2026-07-10

Buyer: Chemins de fer fédéraux suisses CFF, Infrastructure - Achat, Supply Chain et Production, Achat Construction Site de Berne | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-07-10

Buyer: Sociale Verzekeringsbank | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-10

Buyer: AMENAGEMENT 77 | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-07-10

Buyer: Gemeente Zaanstad | Notice type: cn-social | Procedure: open | Contract: services | Deadline: 2026-07-10

Buyer: Miejskie Przedsiębiorstwo Wodociągów i Kanalizacji S.A. | Notice type: pin-rtl | Contract: supplies | Deadline: 2026-07-10

Buyer: Louth and Meath Education and Training Board 1384 | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-10

On behalf of the Office of the Secretary of War/Office of the Under Secretary of War (Acquisition and Sustainment) (OUSD(A&S)) the Washington Headquarters Services, Acquisition Directorate, (WHS/AD) seeks applications for sole-source awards from the National September 11 Memorial & Museum and the Pentagon Memorial Fund.  

This Notice of Funding Opportunity (NOFO) solicits cooperative agreement research applications to support a multidisciplinary program titled "Accelerating Product Excellence in Innovation and for Clinical Adoption" (APEx), that will facilitate advancement of promising strategies and products for tissue engineering and regenerative medicine (TE/RM). APEx will be composed of Resource Centers (RCs) and associated Interdisciplinary Translational Projects (ITPs) in the area of therapeutics (including adult stem cell-based treatments), sensors, and diagnostics. RCs will capitalize on their available clinical, scientific, industrial, regulatory and commercialization expertise, to deliver technical support, research capacity, administrative infrastructure and regulatory and commercialization support to the ITPs and guide them to complete pre-clinical studies toward initiation of clinical trials. During this funding cycle, APEx will complete validation, manufacturing, and preclinical testing of the most promising products, which may include, but are not limited to products for detecting or treating tissue damage caused by congenital defect, traumatic injury, or chronic disease. Products that support early detection of chronic pathologies, monitoring of validated biomarkers of health or disease, as well as approaches to reduce or prevent resulting damage, are especially encouraged. The outcome of APEx will be TE/RM products with their regulatory approvals in place for first-in-human studies, along with associated clinical study protocols, and synthesis and manufacturing protocols rea...